(Q38129528)

29 August 2017

Future treatment strategies in ST-segment elevation myocardial infarction (English)

1 reference

29 August 2017

1

Stephan Windecker

1 reference

29 August 2017

2

Jeroen J Bax

1 reference

29 August 2017

4

Gregg W Stone

1 reference

29 August 2017

Aung Myat

3

1 reference

PubMed ID

23953388

29 August 2017

Michael S Marber

series ordinal

5

1 reference

PubMed ID

23953388

29 August 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

382

1 reference

29 August 2017

9892

1 reference

29 August 2017

644-657

1 reference

Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?

29 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Enhancing the efficacy of delivering reperfusion therapy: a European and North American experience with ST-segment elevation myocardial infarction networks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Strategies for reducing the door-to-balloon time in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Implementation and Integration of Prehospital ECGs Into Systems of Care for Acute Coronary Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Time to treatment in primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Relative Prognostic Value of Baseline Q Wave and Time from Symptom Onset Among Men and Women With ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

The Guardian: an implantable system for chronic ambulatory monitoring of acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Level 1 cardiac arrest centers: learning from the trauma surgeons.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Regional systems of care for out-of-hospital cardiac arrest: A policy statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Cardiac receiving centers: beyond hypothermia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Optimal treatment of patients surviving out-of-hospital cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Manual chest compression vs use of an automated chest compression device during resuscitation following out-of-hospital cardiac arrest: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Use of an automated, load-distributing band chest compression device for out-of-hospital cardiac arrest resuscitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Drug-eluting coronary-artery stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Coronary risk factors and plaque morphology in men with coronary disease who died suddenly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Pathology of the vulnerable plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Epilogue: what do clinicians expect from imagers?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

A prospective natural-history study of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Mechanisms of acute coronary syndromes and their implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Selective clearance of macrophages in atherosclerotic plaques by autophagy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Cardioprotection: chances and challenges of its translation to the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Myocardial ischemia-reperfusion injury: a neglected therapeutic target.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Intracoronary Hemodynamic Effects of Pressure-Controlled Intermittent Coronary Sinus Occlusion (PICSO): Results from the First-In-Man Prepare PICSO Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Controversies in ventricular remodelling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Novel therapeutic approaches to post-infarction remodelling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Effect of peri-infarct pacing early after myocardial infarction: results of the prevention of myocardial enlargement and dilatation post myocardial infarction study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Regeneration gaps: observations on stem cells and cardiac repair

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Regenerating new heart with stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

1 reference

7 January 2021

Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Stem-cell therapy for cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Evidence that human cardiac myocytes divide after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

MicroRNAs add a new dimension to cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Functional screening identifies miRNAs inducing cardiac regeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

A boost for heart regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Evidence for cardiomyocyte renewal in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Cardiomyogenesis in the adult human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Autologous bone-marrow stem-cell transplantation for myocardial regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961452-X

7 January 2021

10.1016/S0140-6736(13)61452-X

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23953388